Piperidine derivatives as NK3 receptor antagonists

Details for Australian Patent Application No. 2008297251 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Knust, Henner; Nettekoven, Matthias; Ratni, Hasane; Wu, Xihan; Vifian, Walter

Agent Spruson & Ferguson

Pub. Number AU-A-2008297251

PCT Pub. Number WO2009/033995

Priority 07116441.2 14.09.07 EP

Filing date 4 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

18 March 2010 PCT application entered the National Phase

  PCT publication WO2009/033995 Priority application(s): WO2009/033995

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008297315-Method for producing silane-modified copolymers

2008297220-Process for producing purified synthesis gas from synthesis gas comprising trace amounts of sulphur contaminants with a metal-organic framework